CI vs EXAS · P/E 2.4, rev $274.90B vs rev $2.76B
Cigna Corp (CI) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the CI and EXAS stock pages for the full models.
Not investment advice.